Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial update on the efficacy and safety of bimatoprost sustained-release (SR) for open-angle glaucoma or ocular hypertension has com…
-
FDA approval · 2020-04-03FDA Approved: TIMOLOL MALEATE — Supplemental Application (Pacific Pharma, Inc.)
FDA approved a supplemental application for timolol maleate from Pacific Pharma, Inc. under the ANDA. The action supplements the existing ap…
-
FDA approval · 2020-04-03FDA Approved: TIMOLOL MALEATE — Supplemental Application (Pacific Pharma, Inc.)
The FDA approved a supplemental application for timolol maleate submitted by Pacific Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: The EASE Study - Human Factor and Usability Testing of a Binocular OCT System
A completed usability study of a binocular OCT system (The EASE Study) assessing human factors across glaucoma and retinal disease condition…
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Effect on the Adherence to Glaucoma Eye Drops by Improving Patient Understanding and Using a Tele-reminder System [Phase 2]
Phase 2 trial assessing how improved patient understanding and a tele-reminder system affect adherence to glaucoma eye drops.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-02Clinical Trial Update: Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]
Phase 3 bioequivalence study comparing brinzolamide 1% suspension to Azopt 1% suspension in chronic open-angle glaucoma or ocular hypertensi…
-
FDA label_change · 2020-02-21FDA Approved: LATANOPROST — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for latanoprost submitted by Bausch & Lomb Incorporated.
-
FDA approval · 2020-02-19FDA Approved: LATANOPROST — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for latanoprost submitted by Somerset Therapeutics, LLC.
-
FDA approval · 2020-02-19FDA Approved: LATANOPROST — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for latanoprost from Rising Pharma Holdings, Inc., indicating a supplemental approval for this gener…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied [Phase 3]
A Phase 3 trial evaluating how aflibercept works in Japanese patients with neovascular glaucoma, focusing on safety and tolerability of intr…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Home Tonometry With the I-care Tonometer for Glaucoma
A completed clinical trial evaluating home tonometry with the I-care tonometer for monitoring glaucoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno® [Phase 1]
Phase 1 trial update evaluating safety and tolerability of preservative-free ophthalmic solution PRO-122 vs Krytantek Ofteno in glaucoma.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan® [Phase 1]
Phase 1 clinical trial comparing safety and tolerability of ophthalmic PRO-179 to Travatan in glaucoma.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: CATS Tonometer IOP Reduction Latanoprost Verses Timolol [Phase 4]
Phase 4 trial comparing CATS tonometer IOP reduction using Latanoprost versus Timolol in glaucoma.
-
FDA approval · 2019-11-25FDA Approved: PILOCARPINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approves Somerset Therapeutics, LLC original application for pilocarpine hydrochloride ophthalmic solution (generic).
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients. [Phase 4]
Phase 4 clinical trial update assessing efficacy and safety of Xalost S in glaucoma patients.
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure [NA]
Completed clinical trial investigating diurnal and nocturnal effects of pilocarpine on intraocular pressure and ocular perfusion pressure.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: How Has Glaucoma Affected Your Quality of Life? [NA]
A completed clinical trial assessing how glaucoma affects quality of life, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Is the RAPDx Pupillograph Able to Distinguish Between Glaucoma Subjects and Healthy Subjects? [NA]
A completed clinical trial evaluating whether the RAPDx Pupillograph can distinguish between glaucoma subjects and healthy controls, with re…
-
FDA approval · 2019-10-18FDA Approved: ACETAZOLAMIDE — Original Application (Eywa Pharma Inc)
FDA approved acetazolamide from Eywa Pharma Inc under an original application (ANDA 211556), making a generic version of the drug available.
-
FDA approval · 2019-10-17FDA Approved: ACETAZOLAMIDE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' Original Application for acetazolamide, granting approval of a generic version.
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma [Phase 2]
Phase 2 trial assessing safety and efficacy of ENV515 Travoprost Extended Release (XR) in patients with Bilateral Ocular Hypertension or Pri…
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: Treatment of Patients With Optic Nerve Damage Patients Using Electrostimulation [Phase 1, Phase 2]
Early-stage clinical trial updates are reported for an electrostimulation approach to treat optic nerve damage in glaucoma, covering Phase 1…
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Heidelberg Edge Perimetry (HEP) Detecting Glaucomatous Visual Field Defects [NA]
Completed clinical trial evaluating Heidelberg Edge Perimetry (HEP) for detecting glaucomatous visual field defects; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Effects of Palmitoylethanolamide on Inner Retinal Function in Glaucoma Patients by Pattern Electroretinogram [Phase 2]
Phase 2 clinical trial assessing palmitoylethanolamide effects on inner retinal function in glaucoma patients using pattern electroretinogra…